1. Home
  2. MOGO vs FGEN Comparison

MOGO vs FGEN Comparison

Compare MOGO & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • FGEN
  • Stock Information
  • Founded
  • MOGO 2003
  • FGEN 1993
  • Country
  • MOGO Canada
  • FGEN United States
  • Employees
  • MOGO N/A
  • FGEN N/A
  • Industry
  • MOGO
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • FGEN Health Care
  • Exchange
  • MOGO Nasdaq
  • FGEN Nasdaq
  • Market Cap
  • MOGO 32.5M
  • FGEN 34.5M
  • IPO Year
  • MOGO N/A
  • FGEN 2014
  • Fundamental
  • Price
  • MOGO $1.27
  • FGEN $0.50
  • Analyst Decision
  • MOGO Strong Buy
  • FGEN
  • Analyst Count
  • MOGO 1
  • FGEN 0
  • Target Price
  • MOGO $6.00
  • FGEN N/A
  • AVG Volume (30 Days)
  • MOGO 66.3K
  • FGEN 877.7K
  • Earning Date
  • MOGO 03-19-2025
  • FGEN 02-24-2025
  • Dividend Yield
  • MOGO N/A
  • FGEN N/A
  • EPS Growth
  • MOGO N/A
  • FGEN N/A
  • EPS
  • MOGO N/A
  • FGEN N/A
  • Revenue
  • MOGO $30,995,226.00
  • FGEN $180,015,000.00
  • Revenue This Year
  • MOGO N/A
  • FGEN $21.91
  • Revenue Next Year
  • MOGO $3.73
  • FGEN N/A
  • P/E Ratio
  • MOGO N/A
  • FGEN N/A
  • Revenue Growth
  • MOGO N/A
  • FGEN 16.15
  • 52 Week Low
  • MOGO $0.94
  • FGEN $0.18
  • 52 Week High
  • MOGO $2.25
  • FGEN $2.93
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 44.79
  • FGEN 49.50
  • Support Level
  • MOGO $1.16
  • FGEN $0.46
  • Resistance Level
  • MOGO $1.34
  • FGEN $0.51
  • Average True Range (ATR)
  • MOGO 0.07
  • FGEN 0.05
  • MACD
  • MOGO 0.00
  • FGEN -0.01
  • Stochastic Oscillator
  • MOGO 40.48
  • FGEN 31.25

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Share on Social Networks: